Key players are adopting inorganic growth strategies such as merger and acquisition to retain their position in the market. For instance, in 2017, Becton Dickinson completed the acquisition of C.R. Bard, Inc., both companies will lead a position to improve the treatment of disease for patients and the process of care for health care providers. Furthermore, in April 2018, B. Braun Melsungen AG started five new and enhanced production plants and other administrative buildings in Penang to manufacture medical devices for infusion therapy and surgical instruments for the treatment of patients in Malaysia and across the world.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients